{"id":"W2019831277","doi":"10.1158/0008-5472.sabcs12-s3-3","title":"Abstract S3-3: The UK TACT2 Trial: comparison of standard vs accelerated epirubicin in patients requiring chemotherapy for early breast cancer (EBC) (CRUK/05/019)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Epirubicin; Medicine; Tolerability; Internal medicine; Breast cancer; Capecitabine; Regimen; Oncology; Chemotherapy; Cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002101825,0.001053367,0.001991839,0.0003061038,0.0002733135,0.0008493861,0.0007054654,0.001204924,0.009264712],"category_scores_gemma":[0.001934379,0.0003958802,0.001854521,0.0006661012,0.0005916424,0.0006250055,0.000361927,0.002182733,0.001223617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046948,"about_ca_system_score_gemma":0.0009997026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001605059,"about_ca_topic_score_gemma":0.003250229,"domain_scores_codex":[0.9986742,0.0009798339,0.00007361211,0.0001142084,0.00006988057,0.00008841679],"domain_scores_gemma":[0.9991134,0.0002176299,0.0002935339,0.00008119124,0.00005272967,0.0002413803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9763575,0.001921698,0.001051565,0.0006336762,0.0006807404,0.00004022009,0.0000332586,0.0004674651,0.002201442,0.00009000134,0.002241159,0.01428125],"study_design_scores_gemma":[0.9161872,0.07443526,0.005809713,0.00006405813,0.0007508657,0.00007901521,0.00001683951,0.0004928072,0.0004833944,0.00009682735,0.001566202,0.00001782174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649084,0.01101549,0.001042592,0.001854651,0.0006312234,0.006069403,0.007357484,0.0001590121,0.006961589],"genre_scores_gemma":[0.9759582,0.002810279,0.001586172,0.001614283,0.0006008559,0.004878062,0.005860617,0.00004191831,0.006649429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009264712,"threshold_uncertainty_score":0.03099352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1132782989483474,"score_gpt":0.4479687772204486,"score_spread":0.3346904782721013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}